首页> 外国专利> Novel bispecific antibody molecules and bispecific antibodies that bind PD-L1 and LAG-3 simultaneously

Novel bispecific antibody molecules and bispecific antibodies that bind PD-L1 and LAG-3 simultaneously

机译:新的双特异性抗体分子和双特异性抗体同时结合PD-L1和LAG-3

摘要

the present invention Polypeptide chain of formula (I): VH-CH1-Fc-X-VHH; and Polypeptide chain of formula (II): VL-CL; here: wherein VH represents a heavy chain variable region; CH represents the heavy chain constant region; said Fc comprises CH2, CH3 and optionally CH4; wherein CH1, CH2, CH3 and CH4 represent domains 1, 2, 3 and 4 of the heavy chain constant region, respectively; wherein X is absent or when present represents a linker such as a flexible linker; said VHH represents a single domain antigen binding site, such as a single domain antibody; said VL represents the light chain variable region; CL represents the light chain constant region; Optionally, a hinge region exists between the CH1 and the Fc, and provides a novel artificially designed antibody molecule.
机译:本发明式(I)的多肽链:VH-CH1-FC-X-VHH; 和多肽式(II)的多肽链:VL-CL; 这里:其中VH表示重链可变区; CH代表重链恒定区域; 所述Fc包括CH2,CH3和任选的CH 4; 其中CH1,CH 2,CH3和CH4分别代表重链恒定区的结构域1,2,3和4; 其中x不存在或者当存在时表示诸如柔性接头的接头; 所述VHH表示单一结构域抗原结合位点,例如单一结构域抗体; 所述VL表示轻链可变区; CL代表轻链恒定区; 任选地,在CH1和Fc之间存在铰链区域,并提供一种新颖的人工设计的抗体分子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号